Incidence and management of adverse events in patients with relapsed and/or refractory multiple myeloma receiving single-agent carfilzomib
about
Carfilzomib, lenalidomide, and dexamethasone in patients with relapsed multiple myeloma categorised by age: secondary analysis from the phase 3 ASPIRE studyPhase 1 study of marizomib in relapsed or relapsed and refractory multiple myeloma: NPI-0052-101 Part 1Synergistic anti-myeloma activity of the proteasome inhibitor marizomib and the IMiD immunomodulatory drug pomalidomide.New developments in the management of relapsed/refractory multiple myeloma - the role of ixazomib.Targeting proteasome ubiquitin receptor Rpn13 in multiple myeloma.Marizomib irreversibly inhibits proteasome to overcome compensatory hyperactivation in multiple myeloma and solid tumour patients.Breakthroughs in modern cancer therapy and elusive cardiotoxicity: Critical research-practice gaps, challenges, and insights.
P2860
Q33626064-764BD73E-BB93-46A8-BD51-4BB290549FE9Q33627312-C166F0E8-D795-42D2-9A89-C6E850D3C66BQ36470302-745CDDAF-DB1A-4695-8076-6EDB9DA7D3E8Q38598891-1E200CF9-4227-4FA3-AB20-DB468A9998C6Q39818766-3EC1C88C-E59B-4037-9951-F9B271582569Q41607725-C47BD56A-DA62-4054-9C16-F9688C758007Q49315568-DD937264-FFB4-482C-A006-A61ABF563F21
P2860
Incidence and management of adverse events in patients with relapsed and/or refractory multiple myeloma receiving single-agent carfilzomib
description
2014 nî lūn-bûn
@nan
2014 թուականին հրատարակուած գիտական յօդուած
@hyw
2014 թվականին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Incidence and management of ad ...... iving single-agent carfilzomib
@ast
Incidence and management of ad ...... iving single-agent carfilzomib
@en
Incidence and management of ad ...... iving single-agent carfilzomib
@nl
type
label
Incidence and management of ad ...... iving single-agent carfilzomib
@ast
Incidence and management of ad ...... iving single-agent carfilzomib
@en
Incidence and management of ad ...... iving single-agent carfilzomib
@nl
prefLabel
Incidence and management of ad ...... iving single-agent carfilzomib
@ast
Incidence and management of ad ...... iving single-agent carfilzomib
@en
Incidence and management of ad ...... iving single-agent carfilzomib
@nl
P2860
P3181
P356
P1476
Incidence and management of ad ...... iving single-agent carfilzomib
@en
P2093
Donald Harvey
P2860
P3181
P356
10.2147/CPAA.S62512
P407
P577
2014-01-01T00:00:00Z